Clinical studies of ABC-transporters contribution to the multidrug resistance of breast cancer
Vol. 62 No. 1 (2016), Articles
Vol. 62 No. 1 (2016)

Clinical studies of ABC-transporters contribution to the multidrug resistance of breast cancer

Articles
https://doi.org/10.37469/0507-3758-2016-62-1-45-52
Published 15.12.2016
Laboratory of Oncovirology, Tomsk Research Institute of Oncology; Laboratory of Translational Cell and Molecular Biomedicine, National Research Tomsk State University
Laboratory of Oncovirology, Tomsk Research Institute of Oncology; Laboratory of Translational Cell and Molecular Biomedicine, National Research Tomsk State University
PDF (Русский)

Keywords

ABC-transporters
multidrug resistance
breast cancer
neoadjuvant chemotherapy
survival

How to Cite

, & . (2016). Clinical studies of ABC-transporters contribution to the multidrug resistance of breast cancer. Voprosy Onkologii, 62(1), 45–52. https://doi.org/10.37469/0507-3758-2016-62-1-45-52
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

This review summarizes the clinical trials of the relationship of gene expression and protein ABC-transporters in breast cancer with the response to neoadjuvant chemotherapy (NAC) and survival of patients. In a large clinical material is considered the pre-treatment multidrug resistance (MDR) and adaptive MDR, that occurs in tumor cells during chemotherapy. Association pre-treatment MDR with NAC efficiency and survival is highly variable and not well-established. In all clinical trials, adaptive MDR showed a good association with NAC efficiency and survival of patients. The own results showed that 5-year distant metastasis-free survival was 73-78% and good response to NAC in patients with a decrease in ABC- expression. The up-regulation of these genes during NAC was related to a significant decrease (up to 50-55%) in metastasis-free survival and poor response to NAC. In the development of strategies to overcome MDR phenotype it is concluded based on the submitted clinical data.
https://doi.org/10.37469/0507-3758-2016-62-1-45-52
PDF (Русский)

References

Литвяков н.В. Градиентный феномен экспрессии генов множественной лекарственной устойчивости в опухоли молочной железы при проведении неоадъювантной химиотерапии: связь с прогрессированием заболевания // Сибирский онкологический журнал. - 2013. - Т. 58. - № 4. - С. 5-11.

Литвяков Н.В., Гарбуков Е.Ю., Слонимская Е.М. и др.Связь безметастатической выживаемости больных раком молочной железы и вектора изменения экспрессии генов множественной лекарственной устойчивости в опухоли при проведении неоадъювантной химиотерапии // Вопр. онкол. - 2013. - Т. 59. - № 3. - С. 334-340.

Allen J.D., Brinkhuis R.F., van Deemter L. et al. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance // Cancer Research. - 2000. - Vol. 60. - N 20. - P 5761-5766.

Amiri-Kordestani L., Basseville A., Kurdziel K. et al. Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies // Drug Resistance Updates. - 2012.

Atalay C., Deliloglu Gurhan I., Irkkan C., Gunduz U. Multidrug resistance in locally advanced breast cancer // Tumour Biol. - 2006. - Vol. 27. - N 6. - P. 309-18.

Burger H., Foekens J.A., Look M.P et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response // Clin Cancer Res. - 2003. - Vol. 9. - N 2. - P. 827-36.

Chen K.G., Sikic B.I. Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance // Clinical Cancer Research. - 2012. - Vol. 18. - N 7. - P. 1863-1869.

Chevillard S., Pouillart P., Beldjord C. et al. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy // Cancer. - 1996. - Vol. 77. - N 2. - P. 292-300.

Chintamani, Singh J.P, Mittal M.K. et al. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-- a prospective clinical study // World J Surg Oncol. - 2005. - Vol. 3. - P 61.

Chintamani, Singh J.P, Mittal M.K. et al. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study // World J Surg Oncol. - 2005. - Vol. 3. - N 1. - P. 61.

Clarke R., Leonessa F., Trock B. Multidrug resistance/Pglycoprotein and breast cancer: review and meta-analysis // Semin Oncol. - 2005. - Vol. 32. - N 6 Suppl 7. - P S9-15.

Dixon A., Bell J., Ellis I. et al. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy // British Journal of Cancer. - 1992. - Vol. 66. - N 3. - P. 537-541.

Eechoute K., Sparreboom A., Burger H. et al. Drug transporters and imatinib treatment: implications for clinical practice // Clinical Cancer Research. - 2011. - Vol. 17. - N 3. - P. 406-415.

Faneyte I.F., Kristel P.M., Maliepaard M. et al. Expression of the breast cancer resistance protein in breast cancer // Clin Cancer Res. - 2002. - Vol. 8. - N 4. - P. 1068-74.

Faneyte I.F., Kristel P.M., van de Vijver M.J. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer // Anticancer Res. - 2004. - Vol. 24. - N 5A. - P. 2931-9.

Filipits M., Pohl G., Rudas M. et al. Clinical role of multi-drug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group // Journal of Clinical Oncology. - 2005. - Vol. 23. - N 6. - P. 1161-1168.

Gillet J.P S.J., Bertholet V., De Longueville F. et al. Micro-array expression profiling of ABC transporters in human breast cancer // Cancer Genomics-Proteomics. - 2006. - Vol. 3. - N 2. - P. 97-106.

Gillet J.P, Gottesman M.M. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1 // Drug Resist Updat. - 2012. - Vol. 15. - N 1-2. - P 2-4.

Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research // FEBS letters. - 2006. - Vol. 580. - N 4. - P. 998-1009.

Hembruff S.L., Laberge M.L., Villeneuve D.J. et al. Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance // BMC Cancer. - 2008. -Vol. 8. - N 1. - P. 318.

Hlavac V., Brynychova V., Vaclavfkova R. et al. The expression profile of ATP-binding cassette transporter genes in breast carcinoma // Pharmacogenomics. - 2013. - Vol. 14. - N 5. - P 515-529.

Honorat M., Mesnier A., Vendrell J. et al. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor a expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells // Endocrine-related cancer. - 2008. - Vol. 15. - N 1. - P 125-138.

Kanzaki A., Toi M., Nakayama K. et al. Expression of multidrug resistance-related transporters in human breast carcinoma // Jpn J Cancer Res. - 2001. - Vol. 92. - N 4. - P. 452-458.

Kathawala R.J., Gupta P, Ashby C.R., Chen Z.-S. The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade // Drug Resistance Updates. - 2015. - Vol. 18. - P. 1-17.

Kerr I.D., Haider A.J., Gelissen I.C. The ABCG family of membrane-associated transporters: you don’t have to be big to be mighty // British journal of pharmacology. - 2011. - Vol. 164. - N 7. - P. 1767-1779.

Kim B., Fatayer H., Hanby A.M. et al. Neoadjuvant Chemotherapy Induces Expression Levels of Breast Cancer Resistance Protein That Predict Disease-Free Survival in Breast Cancer // PLoS ONE. - 2013. - Vol. 8. - N 5. - P. e62766.

Kool M., de Haas M., Scheffer G.L. et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines // Cancer Research. - 1997. - Vol. 57. - N 16. - P. 3537-3547.

Kuo M.T. Roles of multidrug resistance genes in breast cancer chemoresistance // Adv Exp Med Biol. - 2007. -Vol. 608. - P. 23-30.

Larkin A., O’Driscoll L., Kennedy S. et al. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study // Int J Cancer. - 2004. - Vol. 112. - N 2. - P. 286-294.

Leonard G.D., Fojo T., Bates S.E. The role of ABC transporters in clinical practice // The Oncologist. - 2003. - Vol. 8. - N 5. - P. 411-424.

Leonessa F., Clarke R. ATP binding cassette transporters and drug resistance in breast cancer // Endocr Relat Cancer. - 2003. - Vol. 10. - N 1. - P. 43-73.

Litviakov N.V., Cherdyntseva N.V., Tsyganov M.M. et al.Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response // Cancer Chemotherapy and Pharmacology. - 2013. -Vol. 71. - N 1. - P 153-163.

Lockhart A.C., Tirona R.G., Kim R.B. Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy1 // Molecular Cancer Therapeutics. -2003. - Vol. 2. - N 7. - P. 685-698.

Maciejczyk A., Jagoda E., Wysocka T. et al. ABCC2 (MRP2, cMOAT) Localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome // Pathology & Oncology Research. - 2012. - P 1-12.

Moureau-Zabotto L., Ricci S., Lefranc J.P et al. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients // Br J Cancer. - 2006. - Vol. 94. - N 4. - P. 473-480.

Nooter K., de la Riviere G.B., Look M. et al. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer // British Journal of Cancer. - 1997. - Vol. 76. - N 4. - P. 486.

Park S., Shimizu C., Shimoyama T. et al. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients // Breast Cancer Res Treat. - 2006. - Vol. 99. - N 1. - P. 9-17.

Pratt S., Shepard R.L., Kandasamy R.A. et al. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites // Mol Cancer Ther. - 2005. - Vol. 4. - N 5. - P. 855-863.

Rocchi E., Khodjakov A., Volk E.L. et al. The Product of the ABC Half-Transporter Gene< i> ABCG2(BCRP/ MXR/ABCP) Is Expressed in the Plasma Membrane // Biochemical and biophysical research communications. - 2000. - Vol. 271. - N 1. - P. 42-46.

Rudas M., Filipits M., Taucher S. et al. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy // Breast Cancer Research and Treatment. - 2003. - Vol. 81. - N 2. - P. 149-157.

Schinkel A.H., Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview // Advanced drug delivery reviews. - 2012. - Vol. 64. - P. 138-153.

Schneider J., Gonzalez-Roces S., Pollan M. et al. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy // Breast Cancer Research. - 2001. - Vol. 3. - N 3. - P. 183-191.

Singh L.C., Chakraborty A., Mishra A.K. et al. Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women // Med Oncol. - 2012. - Vol. 29. - N 2. - P. 539-546.

Surowiak P., Materna V., Matkowski R. et al. Relationship between the expression of cyclooxygenase 2 and MDR1/ P-glycoprotein in invasive breast cancers and their prognostic significance // Breast Cancer Res. - 2005. -Vol. 7. - N 5. - P. R862-870.

Szakacs G., Annereau J.P., Lababidi S. et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells // Cancer Cell. - 2004. - Vol. 6. - N 2. - P. 129-137.

Szakacs G., Paterson J.K., Ludwig J.A. et al. Targeting multidrug resistance in cancer // Nat Rev Drug Discov. -2006. - Vol. 5. - N 3. - P. 219-234.

Szakacs G., Varadi A., Özvegy-Laczka C., Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) // Drug discovery today. - 2008. - Vol. 13. - N 9. - P. 379-393.

Szakacs G., Wah K.K., Polgar O. et al. Multidrug resistance mediated by MDR-ABC transporters // Drug Resistance in Cancer Cells. - 2009. - P. 1-20.

Tamaki A., lerano C., Szakacs G. et al. The controversial role of ABC transporters in clinical oncology // Essays in Biochemistry. - 2011. - Vol. 50. - N 1. - P. 209-232.

Trock B.J., Leonessa F., Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance // J Natl Cancer Inst. - 1997. - Vol. 89. - N 13. - P. 917-931.

Tusnady G.E., Sarkadi B., Simon I., Varadi A. Membrane topology of human ABC proteins // FEBS letters. - 2006. - Vol. 580. - N 4. - P. 1017-1022.

Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold // The EMBO journal. - 1982. - Vol. 1. - N 8. - P. 945.

Wang C.S., Larue H., Fortin A., Gariépy G., Têtu B. mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy // Breast Cancer Research and Treatment. - 1997. - Vol. 45. - N 1. - P. 63-74.

Wind N.S., Holen I. Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies // International Journal of Breast Cancer. - 2011. - P. 1-12.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...